Volume 3, Issue 6 pp. 504-507
Free Access

Inferior Vena Cava Filter Used for Unresectable Renal Cell Carcinoma with Tumor Thrombi

Kazuo Gohji

Corresponding Author

Kazuo Gohji

Departments of Urology, Hyogo Medical Center for Adults, Hyogo, Japan

*Department of Urology, Kobe University School of Medicine, 7–5–1 Kusunoki-cho, Chuo-ku, Kobe 650, Japan.Search for more papers by this author
Koichi Morisue

Koichi Morisue

Departments of Urology, Hyogo Medical Center for Adults, Hyogo, Japan

Search for more papers by this author
Masayuki Okamoto

Masayuki Okamoto

Departments of Urology, Hyogo Medical Center for Adults, Hyogo, Japan

Search for more papers by this author
Masashi Nomi

Masashi Nomi

Departments of Urology, Hyogo Medical Center for Adults, Hyogo, Japan

Search for more papers by this author
Akio Fujii

Akio Fujii

Departments of Urology, Hyogo Medical Center for Adults, Hyogo, Japan

Search for more papers by this author
Sadao Kamidono

Sadao Kamidono

Departments of Urology, Kobe University School of Medicine, Kobe, Japan

Search for more papers by this author
First published: November 1996
Citations: 2

Abstract

A titanium Greenfield inferior vena cava filter was used for the treatment of 2 patients with unresectable renal cell carcinomas with tumor thrombi to prevent a fatal pulmonary embolism induced by tumor clots released during systemic interferon therapy and embolization of the primary tumor. After treatment, the size of the renal cell carcinomas at the primary site and the tumor thrombi decreased by 50%. There were no fatal pulmonary embolisms or complications related to the filter during the observation period (24 and 25 months) after therapy. This method may be useful in the prevention of a fatal pulmonary embolism induced by embolization and systemic interferon therapy in these patients.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.